Results 201 to 210 of about 276,615 (314)

Efficacy and safety of empagliflozin for treating neutropenia and neutrophil dysfunction in paediatric patients with glycogen storage disease type Ib: A systematic review and meta‐analysis

British Journal of Clinical Pharmacology, EarlyView.
Aims Glycogen storage disease type Ib (GSD‐Ib) is a rare genetic disorder causing neutropenia and neutrophil dysfunction in children. G‐CSF has been the primary treatment, but emerging data support the potential of empagliflozin, an SGLT2 inhibitor, as a promising investigational option.
Elizabeth Iwasyk, Ryan Jin, Fabio Tuzzolino, Giusy Ranucci, Donatella Madonia, Alessio Provenzani   +5 more
wiley   +1 more source

Self-Assembly of Human Embryonic-Stem-Cell-Derived Keratinocytes and Fibroblasts into 3D Spheroid Structures for Epidermal Regeneration In Vivo. [PDF]

Cells
Cai C, Liu H, Liu S, Zhao Z, Xu P, Wang Y, Wang J, Yakupu A, Shao J, Pan M, Zhang W, Han C, He F, Dong L, Wang X.   +14 more
europepmc   +1 more source

Organ Transplantation in Medical and Legal Perspectives [PDF]

, 1967
Stickel, Delford L.
core   +2 more sources

Pharmacokinetic‐pharmacodynamic modelling of risankizumab using chronic plaque psoriasis real‐world data

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim Risankizumab is a high‐cost biologic treatment for chronic plaque psoriasis, an immune‐mediated inflammatory disease presenting with painful red scaly skin lesions. Inter‐individual heterogeneity in treatment response may be better addressed with personalised rather than fixed dosing. We sought to develop a pharmacokinetic/pharmacodynamic (
Charlotte M. Thomas, Jessica Ruoheng Wei, David Baudry, Zehra Arkir, Bola Coker, Tejus Dasandi, Kingsley Powell, Monica Arenas‐Hernandez, Jenny Leung, Krystal Rawstron, Chioma Nwaogu, Richard Woolf, Andrew E. Pink, Jonathan Barker, Joseph F. Standing, Catherine H. Smith, Satveer K. Mahil   +16 more
wiley   +1 more source

Matrix-free cryo-microneedles array patch for 3D hair follicle organoids delivery and rapid hair regeneration. [PDF]

Mater Today Bio
Wang S, Sun J, Li Y, Zhou Y, Cai Y, Simayijiang Z, Gu Z, Xie Z.   +7 more
europepmc   +1 more source

Small bowel transplantation in sensitized recipients: Comparison with heart, kidney, and liver grafts [PDF]

, 1994
Demetris, AJ, Fujisaki, S, Murase, N, Starzl, TE, Tanabe, M, Todo, S, Tsamandas, AC   +6 more
core  

Efficacy, safety and cost‐effectiveness of CAR‐T therapy

British Journal of Clinical Pharmacology, EarlyView.
CAR T‐cells demonstrate high efficacy in blood cancers, including ALL, MM and DLBCL. Innovations target solid tumours despite challenges such as antigen escape. Combination therapies enhance the delivery and infiltration of CAR T cells. Toxicity, cost and resistance remain major barriers to clinical use.
Emina Karahmet Sher, Amina Džidić‐Krivić, Emma Pinjic, Nejra Selak, Kanita Omerbasic, Alexandar Chupin, Andrej Belancic, Almir Fajkic   +7 more
wiley   +1 more source

Evaluation of Latent Tuberculosis Infection Risk in Liver Transplant Recipients. [PDF]

J Clin Med
Öz Kahya M, Erol S, Kış Gökçecik D, Kırımker EO, Çınar G, Kocaay AF, Balcı D, Özdemir Kumbasar Ö.   +7 more
europepmc   +1 more source

History of organ transplantation via the two-way paradigm [PDF]

, 1999
Demetris, AJ, Murase, N, Starzl, TE
core  

Case Report: Switching secukinumab to bimekizumab in diffuse cutaneous systemic sclerosis after autologous hematopoietic stem cell transplantation: a case follow-up. [PDF]

Front Immunol
Nagler LK, Strunz PP, Labinsky H, Kroiß A, Gernert M, Schmalzing M.   +5 more
europepmc   +1 more source